10-Q: USANA Health Sciences Reports Third Quarter 2024 Results: Sales and Earnings Decline Amidst Economic Headwinds

USANA Health Sciences experienced a decrease in both sales and earnings for the third quarter of 2024, primarily due to a challenging economic environment impacting customer acquisition and spending.

Summary

• USANA Health Sciences reported a 6.2% decrease in net sales for the third quarter of 2024, totaling $200.2 million, compared to $213.4 million in the same period last year.
• The decline in sales is attributed to a decrease in active customers and a reduction in average customer spending, influenced by a difficult economic climate in key markets.
• Net earnings for the quarter decreased by 6.5% to $10.6 million, down from $11.3 million in the prior-year quarter.
• The company's gross profit margin increased slightly to 80.4%, up from 80.1% in the prior-year quarter, due to lower material costs and favorable market mix.
• Diluted earnings per share (EPS) decreased by 5.1% to $0.56, compared to $0.59 in the third quarter of 2023.
• The company had approximately 452,000 active customers worldwide as of September 28, 2024, a decrease from 464,000 in the prior year.
• Sales to Associates accounted for approximately 52% of Direct-selling segment sales during the nine months ended September 28, 2024.

Sentiment

Score: 4

Explanation: The document presents a mixed picture with declining sales and earnings, but also some positive aspects like improved gross profit margin and cost control. The overall sentiment is negative due to the worse than expected results and the challenging economic environment.

Positives

• Gross profit margin increased slightly to 80.4% due to lower material costs, favorable market mix, price increases, and lower freight expense.
• Associate incentives decreased slightly to 42.0% of net sales due to price increases and a favorable shift in market sales mix.
• Selling, general and administrative expenses decreased in absolute terms due to lower spending on employee related costs, legal costs and meeting and events.
• The company's China subsidiary remitted profits through an annual dividend of $75.8 million to the United States.
• The company amended its credit agreement to replace the Bloomberg Short-Term Bank Yield Index rate with the Secured Overnight Financing Rate (SOFR).

Negatives

• Net sales decreased by 6.2% due to a decline in active customers and average customer spending.
• Net earnings decreased by 6.5% due to decreased sales and higher relative operating expenses.
• Diluted EPS decreased by 5.1% due to lower net earnings.
• The number of active customers decreased by 2.6% year-over-year.
• There were local currency sales declines in most of the markets in the Americas and Europe region.

Risks

• The company's performance is heavily reliant on the direct selling business model and the activities of its independent associates.
• Extensive regulation of the direct selling model and anti-pyramiding laws in various markets pose a risk.
• Operating in China through BabyCare Holdings, Ltd. involves risks related to regulatory changes, data privacy, and economic conditions.
• Changes to the associate compensation plan could negatively impact the business.
• Product liability claims and litigation are potential risks.
• Expansion into new international markets faces challenges and delays.
• Macroeconomic conditions, including inflation and recession, can affect consumer spending.
• Geopolitical tensions and conflicts can disrupt operations.
• Fluctuations in foreign currency exchange rates can impact financial results.
• Data privacy and security breaches pose a risk.
• Supply chain disruptions and raw material shortages can affect production.
• The company must maintain compliance with debt covenants in its credit facility.
• Information technology system failures and cybersecurity attacks are potential risks.
• The company faces human capital risks, including the ability to attract and retain associates and key personnel.

Future Outlook

The company believes its current cash balances, future cash provided by operations, and amounts available under its line of credit will be sufficient to cover its operating and capital needs in the ordinary course of business for the foreseeable future. However, additional financing may be required for expansion, acquisitions, or other reasons.

Management Comments

• Management believes that presentation of certain non-GAAP financial information is meaningful and useful in understanding the activities and business metrics of our operations.
• Management uses constant currency net sales, local currency net sales, and other currency-related financial information terms to discuss our financial results in a way we believe is helpful in understanding the impact of fluctuations in foreign-currency exchange rates.
• Management believes that increasing the number of active customers is consistent with the company's vision of improving the overall health and nutrition of individuals and families around the world.

Industry Context

The direct selling industry is facing challenges due to economic headwinds and changing consumer behavior. USANA's results reflect these broader trends, with a decline in customer acquisition and spending. The company's focus on increasing active customers aligns with industry best practices for growth.

Comparison to Industry Standards

• USANA's performance is being impacted by similar macroeconomic factors affecting other direct selling companies, such as Nu Skin and Herbalife, which have also reported challenges in customer acquisition and sales.
• The shift to SOFR from BSBY in the credit agreement is in line with broader financial industry trends to move away from LIBOR-based rates.
• The company's gross profit margin of 80.4% is relatively high compared to some other companies in the consumer goods sector, indicating a strong pricing power and efficient cost management.
• The decline in active customers is a concern, as customer retention and acquisition are key metrics for direct selling companies. Companies like Amway and Mary Kay also face similar challenges in maintaining and growing their customer base.
• USANA's reliance on the Chinese market is a significant factor, and its performance is closely tied to the economic conditions and regulatory environment in China, similar to other companies with a strong presence in the region.

Stakeholder Impact

• Shareholders may be concerned about the decline in sales and earnings, potentially leading to a decrease in share value.
• Associates may be impacted by the decrease in sales and customer base, potentially affecting their income.
• Employees may be affected by cost-cutting measures and changes in the company's strategy.
• Customers may be impacted by changes in product offerings and pricing.
• Suppliers may be affected by changes in the company's production and purchasing patterns.

Next Steps

• The company will continue its efforts to remediate material weaknesses in internal control over financial reporting.
• The company will continue to monitor and adapt to the challenging economic environment.
• The company will continue to focus on increasing the number of active customers.

Key Dates

Keywords

direct selling, nutritional products, personal care, skincare, USANA, financial results, sales, earnings, active customers, China, Asia Pacific, Americas, Europe, SOFR, credit agreement